<DOC>
	<DOCNO>NCT00879554</DOCNO>
	<brief_summary>The purpose study determine safety tolerability CVX-045 patient advance solid tumor .</brief_summary>
	<brief_title>A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Confirmed advance solid tumor unresponsive currently available therapy , standard therapy . Adequate coagulation , liver renal function . Candidate DCEMRI evaluation . ECOG ( Eastern Cooperative Oncology Group ) performance status 0 1 . Evidence bleed problem . Uncontrolled hypertension . Certain gastrointestinal problem include fistula abscess . Patients primary brain cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Solid Tumors</keyword>
	<keyword>CVX-045</keyword>
</DOC>